Pricing Log in Create free account

Design Therapeutics, Inc. (DSGN) vs WAVE Life Sciences Ltd. (WVE)

Design Therapeutics, Inc. and WAVE Life Sciences Ltd. are both Biotechnology companies. Design Therapeutics, Inc. and WAVE Life Sciences Ltd. are of similar size ($655.9M and $628.6M). Design Therapeutics, Inc. has the higher net margin (0.00% vs −309.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Design Therapeutics, Inc. leads on 10 and WAVE Life Sciences Ltd. on 4.

Valuation

Metric DSGN WVE Biotechnology median
P/E n/m n/m 8.50
P/S 2,851.44 9.74 9.71
P/B 3.19 1.40 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 1,933.76 2.23 9.21
Earnings yield (11.45%) (34.94%) (33.15%)
Free cash flow yield (8.57%) (30.34%) (25.50%)

Profitability

Metric DSGN WVE Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (333.36%) 0.00%
Net margin 0.00% (309.73%) 0.00%
Free cash flow margin 0.00% (295.46%) 0.00%
Return on equity (34.13%) (68.31%) (56.36%)
Return on assets (32.33%) (49.95%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric DSGN WVE Biotechnology median
Revenue growth (TTM) — (30.42%) 6.02%
EPS growth (last fiscal year) (38.64%) (72.86%) 30.26%
Revenue growth, 5-year CAGR — 16.31% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DSGN WVE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 18.86 9.99 4.72
Net debt to EBITDA 2.68 2.92 0.96

Dividend

Metric DSGN WVE Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric DSGN WVE Biotechnology median
Market cap 655.86m 628.58m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack